$Resistant and refractory hypertension: two sides of the same disease?$

Resistant and refractory hypertension: two sides of the same disease?

Abstract Refractory hypertension (RfH) is an extreme phenotype of resistant hypertension (RH), being considered an uncontrolled blood pressure besides the use of 5 or more antihypertensive medications, including a long-acting thiazide diuretic and a mineralocorticoid antagonist. RH is common, with 1...

Full description

Bibliographic Details
Main Authors:	Elizabeth Silaid Muxfeldt, Bernardo Chedier, Cibele Isaac Saad Rodrigues
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Nefrologia 2018-12-01
Series:	Brazilian Journal of Nephrology
Subjects:	Resistant Hypertension, Refractory Hypertension Sympathetic Nervous System Hyperaldosteronism
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002018005045101&lng=en&tlng=en

Similar Items

In the Refractory Hypertension “Labyrinth”. Focus on Primary Hyperaldosteronism
by: O. V. Tsygankova, et al.
Published: (2020-09-01)

Secondary hypertension as a cause of treatment resistance
by: Isabella Sudano, et al.
Published: (2023-12-01)

Screening of Hyperaldosteronism on the Investigation of Secondary Hypertension: Single-centre Experience
by: Gülsüm Bingöl, et al.
Published: (2023-02-01)

Renal sympathetic denervation for resistant hypertension: where do we stand after more than a decade
by: Marco Antônio Peliky Fontes, et al.
Published: (2020-01-01)

Redefining primary hyperaldosteronism as “The Syndrome of Inappropriate Aldosterone Secretion (SIALDS)”: A common but unrecognized cause of hypertension
by: Rajat Lamba
Published: (2023-12-01)

Secondary hyperaldosteronism and hypertension
by: Mijalković Miloš, et al.
Published: (2021-01-01)

Renal Denervation – a Modern Option for Treating Resistant Hypertension
by: Rodean Ioana, et al.
Published: (2020-03-01)

Primary hyperaldosteronism as a possible cause of resistant arterial hypertension
by: Novella M. Chikhladze
Published: (2021-02-01)

Evaluation of screening practices for primary hyperaldosteronism by specialists and general practitioners: an observational, cross-sectional study
by: Giselle Fernandes Taboada, et al.
Published: (2024-06-01)

Prevalence and Clinical Characteristics of Refractory Hypertension
by: Pedro Armario, et al.
Published: (2017-12-01)

Criteria for selecting patients with resistant hypertension for a renal sympathetic denervation
by: T M Ripp, et al.
Published: (2016-08-01)

Molecular Mechanisms of Primary Aldosteronism
by: Sergei G. Tevosian, et al.
Published: (2019-12-01)

Cold Pressor Test as a Predictor of Hypertension
by: Tapas Pramanik, et al.
Published: (2009-07-01)

Renal denervation for the management of resistant hypertension
by: Patel HC, et al.
Published: (2015-12-01)

Resistant and refractory arterial hypertension: similarities and differences, new approaches to diagnosis and treatment
by: A V Aksenova, et al.
Published: (2018-09-01)

Unilateral Carotid Body Resection in Resistant Hypertension
by: Nicholas Paivanas, MD, et al.
Published: (2016-08-01)

Differential effects of eplerenone versus amlodipine on muscle metaboreflex function in hypertensive humans
by: Poghni A. Peri‐Okonny, et al.
Published: (2021-09-01)

Editorial: Case reports in hypertension: 2022
by: Guido Iaccarino
Published: (2023-05-01)

Baroreflex sensitivity differs among same strain Wistar rats from the same laboratory
by: Celso Ferreira, et al.
Published: (2011-09-01)

Confounders of the aldosterone‐to‐renin ratio when used as a screening test in hypertensive patients: A critical analysis of the literature
by: Gregory P. Veldhuizen, et al.
Published: (2021-02-01)

Paradigm shift on the role of mineralocorticoid receptor antagonists in hypertension therapy
by: S. R. Gilyarevsky, et al.
Published: (2023-10-01)

Resistant hypertension: epidemiology and risk factors
by: I. E. Deneka, et al.
Published: (2016-09-01)

Beta-adrenergic reactivity of erythrocyte membranes in various phenotypes of uncontrolled hypertension
by: M. A. Manukyan, et al.
Published: (2024-06-01)

’Malignant’ hypertension from hyperaldosteronism: a case report
by: Krishna Mohan Baradhi, et al.
Published: (2018-05-01)

New data, new studies, new hopes for renal denervation in patients with uncontrolled hypertension
by: Vasilios Papademetriou, et al.
Published: (2019-11-01)

Screening and treatment of endocrine hypertension focusing on adrenal gland disorders: a narrative review
by: Seung Min Chung
Published: (2024-10-01)

Computed tomographic manifestations of celiac ganglia between hypertensive and non‐hypertensive population
by: Wenkai Xiao, et al.
Published: (2023-09-01)

A Complicated Case of Resistant Hypertension
by: Mauro Chiarito, et al.
Published: (2017-10-01)

Renin dependent hypertension caused by accessory renal arteries
by: Pei Lin Chan, et al.
Published: (2018-11-01)

The nature of the course of arterial hypertension in low-renin hyperaldosteronism
by: Novella M Chikhladze
Published: (2019-12-01)

Brief report: Musical improvisation skills can combat labile hypertension
by: Jeffrey A. Corbett, et al.
Published: (2021-11-01)

REFRACTORY HYPERTENSION – MODERN APPROACHES TO DIAGNOSTICS AND TREATMENT
by: A. N. Britov, et al.
Published: (2016-01-01)

The problem of timely diagnosis of primary hyperaldosteronism. Clinical case
by: V.M. Zhdan, et al.
Published: (2023-10-01)

Heart rate variability as a predictor of hypotension after spinal anesthesia in hypertensive patients
by: Tae Dong Kweon, et al.
Published: (2013-10-01)

Disorders Causing Secondary Hypertension in Patients Less Than 45 Years of Age
by: Sayed Tanveer Abbas Gilani, et al.
Published: (2022-11-01)

Concomitant pheochromocytoma and hyperaldosteronism in a 47-year-old man: a case report
by: Fatemeh Majidi, et al.
Published: (2025-01-01)

The effect of medication on the aldosterone‐to‐renin ratio. A critical review of the literature
by: Rawan M. Alnazer, et al.
Published: (2021-02-01)

Primary hyperaldosteronism: challenges in subtype classification
by: Layden Brian T, et al.
Published: (2012-10-01)

Primary hyperaldosteronism: indications for screening
by: Novella M. Chikhladze
Published: (2022-01-01)

Risk of dementia in primary aldosteronism compared with essential hypertension: a nationwide cohort study
by: Namki Hong, et al.
Published: (2023-08-01)